These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 722321)

  • 1. Sequential myocardial scintigraphy with technetium-99m stannous pyrophosphate following myocardial infarction.
    Malin FR; Rollo FD; Gertz EW
    J Nucl Med; 1978 Oct; 19(10):1111-5. PubMed ID: 722321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous display of gated technetium-99m stannous pyrophosphate and gated blood-pool scintigrams.
    Corbett JR; Lewis SE; Dehmer G; Bonte FJ; Parkey RW; Buja LM; Willerson JT
    J Nucl Med; 1981 Aug; 22(8):671-7. PubMed ID: 7264755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic study of persistently positive technetium-99m stannous pyrophosphate myocardial scintigrams and myocytolytic degeneration after myocardial infarction.
    Buja LM; Poliner LR; Parkey RW; Pulido JI; Hutcheson D; Platt MR; Mills LJ; Bonte FJ; Willerson JT
    Circulation; 1977 Dec; 56(6):1016-23. PubMed ID: 923039
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of coronary reperfusion for acute myocardial infarction by emission CT using technetium-99m pyrophosphate].
    Hashimoto T; Kambara H; Nohara R; Fudo T; Uozu K; Tamaki S; Kawai C
    J Cardiol; 1987 Jun; 17(2):231-9. PubMed ID: 2966242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Technetium-99m stannous pyrophosphate myocardial scintigraphy].
    Tada A; Bungyo H; Hisada K
    Rinsho Hoshasen; 1983 Feb; 28(2):345-6. PubMed ID: 6865056
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinicopathologic findings in 52 patients studied by technetium-99m stannous pyrophosphate myocardial scintigraphy.
    Poliner LR; Buja LM; Parkey RW; Bonte FJ; Willerson JT
    Circulation; 1979 Feb; 59(2):257-67. PubMed ID: 758994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased incidence and clinical correlation of persistently abnormal technetium pyrophosphate myocardial scintigrams following acute myocardial infarction in patients with diabetes mellitus.
    Nicod P; Lewis SE; Corbett JC; Buja LM; Henderson G; Raskin P; Rude RE; Willerson JT
    Am Heart J; 1982 May; 103(5):822-9. PubMed ID: 6280468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute subendocardial myocardial infarction: its detection by Tc-99m stannous pyrophosphate myocardial scintigraphy.
    Pulido JI; Parkey RW; Lewis SE; Buja LM; Bonte FJ; Dehmer G; Stone MJ; Willerson JT
    Clin Nucl Med; 1980 May; 5(5):191-5. PubMed ID: 7371345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Count density method for sizing myocardial infarction with Tc-99m-stannous pyrophosphate myocardial scintigraphy].
    Kiriyama T; Kondo T; Watanabe Y; Kaneko K; Kato Y; Sakurai M; Kurokawa H; Hishida H; Mizuno Y; Ejiri K
    Kaku Igaku; 1985 Jan; 22(1):75-9. PubMed ID: 3999458
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction.
    Huckell VF; Lyster DM; Morrison RT; Cooper JA
    Clin Nucl Med; 1985 Jul; 10(7):455-62. PubMed ID: 4028596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphy.
    Willerson JT; Parkey RW; Bonte FJ; Lewis SE; Corbett J; Buja LM
    Semin Nucl Med; 1980 Jan; 10(1):54-69. PubMed ID: 6246640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early positive technetium-99m stannous pyrophosphate images as a marker of reperfusion after thrombolytic therapy for acute myocardial infarction.
    Wheelan K; Wolfe C; Corbett J; Rude RE; Winniford M; Parkey RW; Buja LM; Willerson JT
    Am J Cardiol; 1985 Aug; 56(4):252-6. PubMed ID: 4025161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate in acute myocardial infarction: concise communication.
    Kelly RJ; Chilton H; Hackshaw BT; Ball JD; Watson NE; Kahl FR; Cowan FJ
    J Nucl Med; 1979 May; 20(5):402-6. PubMed ID: 232147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited clinical diagnostic specificity of technetium-99m stannous pyrophosphate myocardial imaging in acute myocardial infarction.
    Ahmad M; Dubiel JP; Logan KW; Verdon TA; Martin RH
    Am J Cardiol; 1977 Jan; 39(1):50-4. PubMed ID: 831427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specificity of pyrophosphate myocardial scintigrams in patients with prior myocardial infarction: concise communication.
    Botvinick EH; Shames DM; Sharpe DN; Klausner SC; Werner JA; Chatterjee K; Parmley WW
    J Nucl Med; 1978 Oct; 19(10):1121-5. PubMed ID: 214527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bayesian analysis of myocardial scintigraphy using 99mTc-Sn(II)-methylenediphosphonate and using 99mTc-Sn(II)-pyrophosphate].
    Cuarón A; Acero A; Cárdenas M
    Arch Inst Cardiol Mex; 1982; 52(5):365-72. PubMed ID: 7149857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of persistently positive technetium-99m pyrophosphate myocardial scintigrams in patients with acute myocardial infarction].
    Nakashima Y; Fukuzaki H; Maeda K; Minamiji K; Kida T; Yoshida Y
    Kaku Igaku; 1984 Mar; 21(3):221-9. PubMed ID: 6088866
    [No Abstract]   [Full Text] [Related]  

  • 18. Technetium-99m stannous pyrophosphate myocardial scintigraphy. Reliability and limitations in assessment of acute myocardial infarction.
    Cowley MJ; Mantle JA; Rogers WJ; Russel RO; Rackley CE; Logic JR
    Circulation; 1977 Aug; 56(2):192-8. PubMed ID: 872310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium 99m stannous pyrophosphate myocardial scintigraphy to detect myocardial necrosis.
    Willerson JT
    West J Med; 1977 Dec; 127(6):510-2. PubMed ID: 595589
    [No Abstract]   [Full Text] [Related]  

  • 20. Validation of technetium-99m stannous pyrophosphate myocardial scintigraphy for diagnosing acute myocardial infarction more than 48 hours old when serum creatine kinase-MB has returned to normal.
    Olson HG; Lyons KP; Butman S; Piters KM
    Am J Cardiol; 1983 Aug; 52(3):245-51. PubMed ID: 6869268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.